Results 11 to 20 of about 3,580,419 (303)

Abscopal Effect Following Cryoablation in a Patient with Metastatic Breast Cancer

open access: yesFrontiers in Bioscience-Scholar, 2023
While breast cancer is a common disease with many available treatment options, many patients still have limited responses, especially those with metastatic breast cancer. Surgery of the primary tumor or metastatic sites is often not part of the treatment
Jamie L. Kaplan   +3 more
doaj   +1 more source

Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models [PDF]

open access: yes, 2015
This research was financed in part by a Grant of the 7th Framework Program of the European Union (METOXIA project; HEALTH‐F2‐2009‐222741) and the NGI Pre- Seed grant (NWO n° 93613002).Triple negative, resistant or metastatic disease are major factors in ...
Kunkler, Ian H.   +30 more
core   +4 more sources

Widespread Alternative Splicing Changes in Metastatic Breast Cancer Cells

open access: yesCells, 2021
Aberrant alternative splicing (AS) is a hallmark of cancer and a potential target for novel anti-cancer therapeutics. Breast cancer-associated AS events are known to be linked to disease progression, metastasis, and survival of breast cancer patients. To
Jagyeong Oh   +10 more
doaj   +1 more source

Breast surgery for metastatic breast cancer [PDF]

open access: yesCochrane Database of Systematic Reviews, 2014
Metastatic breast cancer is not a curable disease, but women with metastatic disease are living longer. Surgery to remove the primary tumour is associated with an increased survival in other types of metastatic cancer. Breast surgery is not standard treatment for metastatic disease, however several recent retrospective studies have suggested that ...
Giuliano, Tosello   +4 more
openaire   +2 more sources

Metastasis: A Bane of Breast Cancer Therapy

open access: yesEuropean Medical Journal, 2020
The underlying mechanisms of metastasis in patients with breast cancer is still poorly understood. Approximately 6% of patients with breast cancer present with metastasis at the time of diagnosis.
Chidalu A. Edechi,   +4 more
doaj   +1 more source

Potential inequities in availability of care from breast care nurses: a qualitative study reporting the experiences and perspectives of women with metastatic breast cancer in Australia

open access: yesBMC Health Services Research, 2022
Background International consensus guidelines recommend patients with metastatic breast cancer have access to a nurse experienced in the treatment of metastatic breast cancer. This study aimed to explore women’s experiences of supportive care from breast
Andrea L. Smith   +2 more
doaj   +1 more source

Prognostic factors and survival outcomes according to tumor subtype in patients with breast cancer lung metastases [PDF]

open access: yesPeerJ, 2019
Background Reports on the incidence and prognoses of lung metastases when diagnosing breast cancer patients with different subtypes are limited. Our study investigated the effect of molecular sub-typing stratification on the prognoses of lung metastatic ...
Siying Chen   +5 more
doaj   +2 more sources

Acute urine retention following medullary compression of metastatic breast cancer in the spinal cord: Rare symptomatlogic presentation and management

open access: yesRadiology Case Reports, 2023
The management of locally advanced and metastatic breast cancer has evolved since 2021, with confirmation of the role of cell cycle inhibitors.The discovery of breast cancer is often the result of self-examination through the discovery of a nodule, but ...
Hammou El Farhaoui   +5 more
doaj   +1 more source

Comparisons of Metastatic Patterns, Survival Outcomes and Tumor Immune Microenvironment Between Young and Non-Young Breast Cancer Patients

open access: yesFrontiers in Cell and Developmental Biology, 2022
Background: Metastases are the main cause of breast cancer-related deaths. Breast cancer has a more aggressive phenotype and less favorable prognosis in young females than in older females.
Hengwen Sun   +4 more
doaj   +1 more source

Lapatinib in Metastatic Breast Cancer [PDF]

open access: yesWomen's Health, 2009
Lapatinib is an oral, small-molecule, dual kinase inhibitor that targets both HER2 and the EGF receptor. Lapatinib was approved in June 2008 in Europe for the treatment of advanced HER2-positive breast cancer. Promising results in trastuzumab-refractory metastatic breast cancer were obtained from Phase I, II and III studies in combination with ...
J-S, Frenel   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy